EcoDrugPlus

Somatostatin Receptor 5

Ensembl ID : ENSGACG00000014537
Gene Symbol: SSTR5
2 Cross references
187 Possible Orthologues:

Sphingosine Kinase 2

Ensembl ID : ENSGACG00000011540
Gene Symbol: SPHK2
1 Cross references
202 Possible Orthologues:

Spleen Tyrosine Kinase

Ensembl ID : ENSGACG00000018650
Gene Symbol: SYK
1 Cross references
203 Possible Orthologues:

Steroid-5-Alpha-Reductase, Alpha Polypeptide 2a

Ensembl ID : ENSGACG00000019899
Gene Symbol: SRD5A2A
1 Cross references
208 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSGACG00000010924
Gene Symbol: SOAT1
1 Cross references
211 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSGACG00000013609
Gene Symbol: TACR1
2 Cross references
214 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSGACG00000016103
Gene Symbol: TACR2
2 Cross references
200 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSGACG00000017903
Gene Symbol: TACR3
2 Cross references
172 Possible Orthologues:

Tachykinin Receptor 3-Like

Ensembl ID : ENSGACG00000017653
Gene Symbol: TACR3L
2 Cross references
201 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSGACG00000009277
Gene Symbol: TERT
1 Cross references
188 Possible Orthologues:

Thromboxane A Synthase 1 (Platelet)

Ensembl ID : ENSGACG00000013260
Gene Symbol: TBXAS1
1 Cross references
220 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSGACG00000008804
Gene Symbol: TBXA2R
1 Cross references
193 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).